Die Ewigkeitschemikalien PFAS sind gerade das meist diskutierte chemikalienpolitische Thema. Insbesondere der Gruppenbeschränkungsvorschlag auf EU-Ebene wird viel diskutiert. Hier tauchen immer wieder Narrative auf, um den Beschränkungsvorschlag zu diskreditieren. In dem Faktencheck räumen wir mit einigen Mythen rund um das Thema PFAS und deren Regulierung auf.
Southern Dental Industries, the world’s leading manufacturer of dental amalgam, announced that it will cease production by 2028 at the latest, as the release of mercury from dental amalgam is a global concern. SDI is the last publicly traded manufacturer fully transitioning to mercury-free alternatives in view of the United Nations ambition to end the trade by 2030.
The EU enables Northern Ireland dentists to continue using dental amalgam until 31 December 2034, or until the date agreed by the global Minamata Convention, to which the UK is a signatory, whichever is earlier. The conditions for the agreement with the EU are regular reporting and proof of continuous progress in reducing the use of amalgam:..
Brussels, 30 May 2024: With the adoption by the Council, the phase-out of dental amalgam by January 2025 has been finalized. The European Parliament had already given its approval on April 10 with a majority of 98%. After being signed by the Presidents of the European Parliament and the Council, the legal act will soon be published in the Official Journal of the European Union and enter into force…
Epidemiologische und Tierversuchsstudien weisen darauf hin, dass bestimmte PFAS Niere und Leber, das Hormon- und Immunsystem schädigen und den Fettstoffwechsel stören, die Wirkung von Impfungen verschlechtern, ein geringeres Geburtsgewicht zur Folge haben, die Fruchtbarkeit verringern oder Krebs erzeugen können…
Stormont risks putting dentists’ wallets over people’s health, say toxics campaigners. Ending Northern Ireland’s use of neurotoxic mercury in tooth fillings will bring significant benefits, without having an adverse impact on everyday life, MLAs have been told…
